The FDA is seeking feedback on its document entitled Decentralized Clinical Trials for Drugs, Biological Products, and Devices Guidance for Industry, Investigators, and Other Stakeholders – this draft Guidance is available at https://www.regulations.gov/document/FDA-2022-D-2870-0002. The deadline to submit comments is August 1.
Updates to Canada’s Strategy for Patient Oriented Research (SPOR)
We are delighted to share a new report on behalf of Canada’s Strategy for Patient Oriented Research (SPOR),...